Quarterly report · Q2
7634.TEDINET S100S91Y
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥13.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥879m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥806m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥908m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥914m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥621m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥560m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥623m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥564m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥21.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥21.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥967m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥816m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥601m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥230m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥454m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥958m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥483m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.16 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.56 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥402.98 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥79m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥380m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥678m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥658m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥264m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥800m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥879m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥402m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥588m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥545m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥193m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥19m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥721m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥806m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 503
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03330-000MedicalGasRelatedReportableSegmentsMember | 192930000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | 402387000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03330-000MedicalGasEquipmentInstallationRelatedReportableSegmentsMember | 102989000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03330-000CareWelfareRelatedReportableSegmentsMember | 3567000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03330-000NursingHomeReportableSegmentsMember | 19381000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 721256000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 84381000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 805637000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasRelatedReportableSegmentsMember | 1863223000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | 3099832000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasEquipmentInstallationRelatedReportableSegmentsMember | 658484000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03330-000CareWelfareRelatedReportableSegmentsMember | 606250000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03330-000NursingHomeReportableSegmentsMember | 173931000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 6401721000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 562271000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 6963992000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasRelatedReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasEquipmentInstallationRelatedReportableSegmentsMember | 19097000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03330-000CareWelfareRelatedReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03330-000NursingHomeReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 19097000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 19097000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasRelatedReportableSegmentsMember | 1863223000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | 3099832000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasEquipmentInstallationRelatedReportableSegmentsMember | 677581000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03330-000CareWelfareRelatedReportableSegmentsMember | 606250000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03330-000NursingHomeReportableSegmentsMember | 173931000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 6420819000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 562271000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 6983090000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasRelatedReportableSegmentsMember | 264349000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | 379703000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E03330-000MedicalGasEquipmentInstallationRelatedReportableSegmentsMember | 121500000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E03330-000CareWelfareRelatedReportableSegmentsMember | 21184000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E03330-000NursingHomeReportableSegmentsMember | 13387000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 800124000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 78568000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 878693000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-11-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第50期第２四半期(自 2023年７月１日 至 2023年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社星医療酸器 | |
| Company name in english cover page | FilingDateInstant | HOSHI IRYO-SANKI CO., LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 星 幸 男 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都足立区入谷七丁目11番18号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)(03)3899-2101(代表) |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |